J D Pirsch
Overview
Explore the profile of J D Pirsch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
173
Citations
1584
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pirsch J, Henning A, First M, Fitzsimmons W, Gaber A, Reisfield R, et al.
Am J Transplant
. 2015 Apr;
15(7):1982-90.
PMID: 25881802
New-onset diabetes after transplantation (NODAT) is an important complication following kidney transplantation. Data from the 5-year early steroid withdrawal double-blind randomized trial were analyzed to determine if steroid avoidance reduced...
2.
Niederhaus S, Leverson G, Lorentzen D, Robillard D, Sollinger H, Pirsch J, et al.
Am J Transplant
. 2013 Oct;
13(11):2945-55.
PMID: 24102905
Antibody-mediated rejection (AMR) after pancreas transplantation is a recently identified entity. We describe the incidence of, risk factors for, and outcomes after AMR, and the correlation of C4d immunostaining and...
3.
Shihab F, Lee S, Smith L, Woodle E, Pirsch J, Gaber A, et al.
Am J Transplant
. 2012 Nov;
13(2):474-84.
PMID: 23167508
As corticosteroid-sparing protocols are increasingly utilized in kidney transplant recipients, it is crucial to understand potential drug interactions between tacrolimus (TAC) and the effect of corticosteroid withdrawal as well as...
4.
Musat A, Agni R, Wai P, Pirsch J, Lorentzen D, Powell A, et al.
Am J Transplant
. 2011 Feb;
11(3):500-10.
PMID: 21342448
The role of humoral alloreactivity in ABO-compatible liver transplantation remains unclear. To understand the significance of donor-specific HLA alloantibodies (DSA) in liver rejection, we applied the currently used strategy for...
5.
Magliocca J, Odorico J, Pirsch J, Becker Y, Knechtle S, Leverson G, et al.
Am J Transplant
. 2008 Aug;
8(8):1702-10.
PMID: 18694474
Alemtuzumab is a humanized, rat monoclonal antibody directed against the CD52 antigen. After binding, alemtuzumab causes profound and durable depletion and has been successfully used as immune induction therapy for...
6.
Sollinger H, Becker Y, Burlingham W, DAlessandro A, Fernandez L, Hullett D, et al.
Clin Transpl
. 2008 Jul;
:271-87.
PMID: 18637475
No abstract available.
7.
Odorico J, Voss B, Munoz del Rio A, Leverson G, Becker Y, Pirsch J, et al.
Transplant Proc
. 2008 Apr;
40(2):513-5.
PMID: 18374117
Preserving kidney function in patients after solitary pancreas transplantation (SPTx) is an important consideration, yet various factors may negatively impact long-term function of the native kidneys or kidney allograft. To...
8.
Yagci G, Fernandez L, Knechtle S, DAlessandro A, Chin L, Musat A, et al.
Transplant Proc
. 2008 Feb;
40(1):219-23.
PMID: 18261591
Morphologic characteristics of the graft have been proposed as a major contributor to the long-term outcomes in orthotopic liver transplantation (OLT). Our objective was to determine the impact of donor...
9.
Safdar N, Slattery W, Knasinski V, Gangnon R, Li Z, Pirsch J, et al.
Clin Infect Dis
. 2005 Apr;
40(10):1413-21.
PMID: 15844063
Background: The epidemiology of candiduria in renal transplantation is unknown. Methods: We performed a nested case-control study to evaluate the epidemiology of candiduria in renal transplant recipients at the University...
10.
Premasathian N, Muehrer R, Brazy P, Pirsch J, Becker B
J Hum Hypertens
. 2004 Aug;
18(12):871-7.
PMID: 15318162
Post-transplant hypertension remains a significant risk factor for graft loss, but whether or not specific blood pressure (BP) medications affect graft outcome is still unknown. We assessed the interaction between...